Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | MMP2 | P08253 | 5/20 | 0.51 |
| ▸ | ANPEP | P15144 | 3/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | PEPD | P12955 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | XPNPEP1 | Q9NQW7 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3783080 | 0.84 | MMP2 (0.72) | ALDH1A1MMP2ANPEPATMMEN1 | |
| SCHEMBL8401942 | 0.84 | ALDH1A1 (0.59) | ALDH1A1MMP2ANPEPATMMEN1 | |
| SCHEMBL10061040 | 0.84 | ALDH1A1 (0.59) | ALDH1A1MMP2ANPEPATMMEN1 | |
| SCHEMBL8401692 | 0.84 | ALDH1A1 (0.59) | ALDH1A1MMP2ANPEPATMMEN1 | |
| SCHEMBL996113 | 0.84 | ALDH1A1 (0.59) | ALDH1A1MMP2ANPEPATMMEN1 | |
| SCHEMBL996114 | 0.84 | ALDH1A1 (0.59) | ALDH1A1MMP2ANPEPATMMEN1 | |
| SCHEMBL3783083 | 0.84 | MMP2 (0.72) | ALDH1A1MMP2ANPEPATMMEN1 | |
| SCHEMBL8401652 | 0.84 | ALDH1A1 (0.59) | ALDH1A1MMP2ANPEPATMMEN1 | |
| SCHEMBL3784082 | 0.84 | MMP2 (0.72) | ALDH1A1MMP2ANPEPATMMEN1 | |
| SCHEMBL3272061 | 0.84 | ALDH1A1 (0.59) | ALDH1A1MMP2ANPEPATMMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070249637-A1 | Inhibitors Of Hepatitis C Virus Protease, And Compositions And Treatments Using The Same | COLLINS MICHAEL R | 2007-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249637-A1 | Inhibitors Of Hepatitis C Virus Protease, And Compositions And Treatments Using The Same | SERPINB1, CTSC, CTSV | ALDH1A1 698/4885MMP2 35/4885ANPEP 43/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.